Dr. Bärbel Hüsing

Fraunhofer Institute for
Systems and Innovation Research ISI


Studies of Biology at the University of Hannover, Germany; Master degree in 1986, University of Hannover

1987: Junior Researcher at Institute of Microbiology, University of Hannover

1987-1990: Junior Researcher at Institute of Biotechnology I, Research Centre Jülich GmbH

Doctoral thesis at the Research Centre Jülich GmbH, Jülich, Germany; Dr. rer. nat. in 1991, Heinrich-Heine-University of Düsseldorf, Düsseldorf, Germany

since 1991: Senior Researcher and Project Manager at Fraunhofer Institute for Systems and Innovation Research ISI, Karlsruhe

1996-2004: deputy head of the department Innovations in Biotechnology

2005-2007: deputy head, August 2006 to March 2007 head of the Competence Center Emerging Technologies

2008-2014: Coordinator of Business Unit Biotechnology and Life Sciences

Work Focus

  • Scientific innovation analyses, strategic and policy advice regarding biotechnology and life sciences 

  • Scientific-technical developments and prospective studies in biotechnology and life sciences 

  • Contribution to coping with societal challenges

  • Frame conditions and influencing factors for innovation processes

  • Impact assessment, technology assessment in emerging technologies, evaluations of funding measures

  • New technologies in the pharmaceutical industry, medicine and the health care system; especially regenerative medicine and tissue engineering, personalised medicine, nanobiotechnology, brain research, RNA technologies, next generation genome sequencing, diagnostics

  • New technologies in the agro-food sector, especially Green Biotechnology, genetically modified crop plants of the 2nd and 3rd generation, Functional Food

  • Contribution of new technologies to environmental protection and sustainability: environmental and health impacts of nanotechnological applications

  • White Biotechnology

Further Reseach Areas

  • Attitudes towards and acceptance of new technologies

  • Deliberative and participative processes about new technologies

  • Technology foresight


  •  Cell-free bioproduction

  •  Translational Research in Genomic Medicine (TRi-Gen)

  •  Making Perfect Life

  •  Analysis of need for action for the Federal Ministry of Economics and Technology (BMWi) in regard tot hte lead-market initiative of the European Commission for bio-based products (excluding bioenergy)

  • Personalised medicine in the future health care system – discourse project

  • Future report: Individualised medicine and the health care system